BCT fundamentals
An in-depth look to BRIACELL THERAPEUTICS CORP operating, investing, and financing activities
BCT free cash flow for Q2 24 is -10.01 M CAD. For 2023, BCT free cash flow was -31.86 M CAD and operating cash flow was -31.86 M CAD.
Q3 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
0.00
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: CAD
Q3 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
TTM